Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ari Zimran

Showing results (91-100 of 238) with videos related to

Pageof 24
Sort By:
Thrombosis and Haemostasis|February 9, 2011
Impaired platelet function and peripartum bleeding in women with Gaucher diseaseMichal J Simchen, Rotem Oz, Boris Shenkman, et al.
Internal Medicine Journal|September 26, 2025
A large long-term database of Gaucher disease patients demonstrates increased risk of lymphoma and myeloma, but not of solid tumoursMajdolen Istaiti, Tama Dinur, Ora Paltiel, et al.
Blood Cells, Molecules & Diseases|December 21, 2016
Growth and final height of children with Gaucher disease: A 15-year follow-up at an Israeli Gaucher centerEspen Mendelsohn, Amos Meir, Aya Abrahamov, et al.
Journal of Clinical Gastroenterology|July 3, 2004
Increased prevalence of cholelithiasis in Gaucher disease: association with splenectomy but not with gilbert syndromeMiriam Ben Harosh-Katz, Michael Patlas, Irith Hadas-Halpern, et al.
American Journal of Hematology|April 24, 2015
Seven-year safety and efficacy with velaglucerase alfa for treatment-naïve adult patients with type 1 Gaucher diseaseAri Zimran, Nan Wang, Carol Ogg, et al.
Advances in Hematology|November 29, 2013
Achievement of therapeutic goals with low-dose imiglucerase in Gaucher disease: a single-center experienceIrina Tukan, Irith Hadas-Halpern, Gheona Altarescu, et al.
The Israel Medical Association Journal : IMAJ|August 22, 2003
Osteonecrosis in a patient with Gaucher's disease treated with enzyme replacementEhud Lebel, Deborah Elstein, Daniel Hain, et al.
Blood Cells, Molecules & Diseases|March 9, 2020
Open-label, expanded access study of taliglucerase alfa in patients with Gaucher disease requiring enzyme replacement therapyDavid J Kuter, Michael Wajnrajch, Betina Hernandez, et al.
International Journal of Molecular Sciences|April 13, 2023
High-Dose Ambroxol Therapy in Type 1 Gaucher Disease Focusing on Patients with Poor Response to Enzyme Replacement Therapy or Substrate Reduction TherapyMajdolen Istaiti, Dafna Frydman, Tama Dinur, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 31, 2015
Thromboelastography as a Surrogate Marker of Perisurgical Hemostasis in Gaucher DiseaseAlexander Ioscovich, Dmitri Fadeev, Gili Kenet, et al.
Pageof 24

Showing results (91-100 of 238) with videos related to

Sort By:
Pageof 24
Thrombosis and Haemostasis|February 9, 2011
Impaired platelet function and peripartum bleeding in women with Gaucher diseaseMichal J Simchen, Rotem Oz, Boris Shenkman, et al.
Internal Medicine Journal|September 26, 2025
A large long-term database of Gaucher disease patients demonstrates increased risk of lymphoma and myeloma, but not of solid tumoursMajdolen Istaiti, Tama Dinur, Ora Paltiel, et al.
Blood Cells, Molecules & Diseases|December 21, 2016
Growth and final height of children with Gaucher disease: A 15-year follow-up at an Israeli Gaucher centerEspen Mendelsohn, Amos Meir, Aya Abrahamov, et al.
Journal of Clinical Gastroenterology|July 3, 2004
Increased prevalence of cholelithiasis in Gaucher disease: association with splenectomy but not with gilbert syndromeMiriam Ben Harosh-Katz, Michael Patlas, Irith Hadas-Halpern, et al.
American Journal of Hematology|April 24, 2015
Seven-year safety and efficacy with velaglucerase alfa for treatment-naïve adult patients with type 1 Gaucher diseaseAri Zimran, Nan Wang, Carol Ogg, et al.
Advances in Hematology|November 29, 2013
Achievement of therapeutic goals with low-dose imiglucerase in Gaucher disease: a single-center experienceIrina Tukan, Irith Hadas-Halpern, Gheona Altarescu, et al.
The Israel Medical Association Journal : IMAJ|August 22, 2003
Osteonecrosis in a patient with Gaucher's disease treated with enzyme replacementEhud Lebel, Deborah Elstein, Daniel Hain, et al.
Blood Cells, Molecules & Diseases|March 9, 2020
Open-label, expanded access study of taliglucerase alfa in patients with Gaucher disease requiring enzyme replacement therapyDavid J Kuter, Michael Wajnrajch, Betina Hernandez, et al.
International Journal of Molecular Sciences|April 13, 2023
High-Dose Ambroxol Therapy in Type 1 Gaucher Disease Focusing on Patients with Poor Response to Enzyme Replacement Therapy or Substrate Reduction TherapyMajdolen Istaiti, Dafna Frydman, Tama Dinur, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 31, 2015
Thromboelastography as a Surrogate Marker of Perisurgical Hemostasis in Gaucher DiseaseAlexander Ioscovich, Dmitri Fadeev, Gili Kenet, et al.
Pageof 24